Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 12.53 Billion | USD 31.34 Billion | 9.6% | 2024 |
FrequentlyAsked Questions
Glucose biosensors are extensively used to supervise and test the concentration of glucose in the blood of the patient.
The global glucose biosensor market is expected to grow due to Increasing diabetes prevalence and demand for real-time glucose monitoring boost market growth. Technological advancements in wearable biosensors support innovation.
According to a study, the global glucose biosensor market size was worth around USD 12.53 Billion in 2024 and is expected to reach USD 31.34 Billion by 2034.
The global glucose biosensor market is expected to grow at a CAGR of 9.6% during the forecast period.
North America is expected to dominate the glucose biosensor market over the forecast period.
Leading players in the global glucose biosensor market include F. Hoffmann-La Roche Ltd., Trividia Health, Inc., Abbott, Dexcom Inc., Medtronic, LifeScan IP Holdings, LLC., and Senseonics, Sanofi, Bayer AG, GlySens Incorporated, and Pinnacle Technologies, Inc. among other global players., among others.
The report explores crucial aspects of the glucose biosensor market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed